pegaptanib sodium

DRUG13 trials

Sponsors

Eyetech Pharmaceuticals, Pfizer, Barnes Retina Institute, Johns Hopkins University

Conditions

Age-Related Macular DegenerationAnti- VGF InhibitorChoroidal NeovascularizationCystoid Macular EdemaDiabetic Macular EdemaDiabetic MellitusDiabetic RetinopathyMacular Degeneration

Phase 1

Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics

TerminatedNCT00346983

Johns Hopkins UniversityCystoid Macular Edema

Start: 2006-06-30End: 2007-05-31Updated: 2008-05-12

The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema

TerminatedNCT00358423

Johns Hopkins UniversityCystoid Macular Edema

Start: 2006-07-31End: 2007-02-28Updated: 2008-05-12

Phase 2

Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)

CompletedNCT00088283

Eyetech PharmaceuticalsRetinal Vein Occlusion

Start: 2004-05-31Target: 90Updated: 2007-01-19

Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration

CompletedNCT00239928

PfizerMacular Degeneration

Start: 2005-09-30End: 2008-11-30Updated: 2011-05-12

A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.

CompletedNCT00321997

Eyetech PharmaceuticalsAge-Related Macular Degeneration

Start: 2001-05-31End: 2007-10-31Target: 540Updated: 2006-05-04

Phase 3

Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)

CompletedNCT00150202

PfizerMacular Degeneration

Start: 2004-07-31End: 2006-10-31Target: 90Updated: 2007-05-07

A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema

CompletedNCT01100307

PfizerDiabetic Mellitus, Macular Edema, Retinal Disease

Start: 2010-05-31End: 2012-08-31Updated: 2013-08-23

Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema

CompletedNCT01189461

PfizerAnti- VGF Inhibitor, Diabetic Macular Edema, Diabetic Retinopathy

Start: 2011-01-31End: 2012-07-31Updated: 2013-09-06

Phase 4

A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)

TerminatedNCT00312351

Eyetech PharmaceuticalsMacular Degeneration

Start: 2006-04-30End: 2006-11-30Target: 262Updated: 2007-01-15

Unknown Phase

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

CompletedNCT00088192

Eyetech PharmaceuticalsMacular Degeneration

Start: 2004-07-31Updated: 2005-08-30

Macugen for Histoplasmosis

TerminatedNCT00272766

Barnes Retina InstituteChoroidal Neovascularization, Ocular Histoplasmosis

Start: 2006-02-28End: 2007-05-31Target: 24Updated: 2006-10-27

Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration

CompletedNCT00845273

PfizerMacular Degeneration

Start: 2008-11-30End: 2014-02-28Updated: 2015-10-02

Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.

CompletedNCT00858208

PfizerNeovascular Age-related Macular Degeneration

Start: 2008-03-31End: 2011-04-30Updated: 2012-04-11

Related Papers

Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study

British Journal of Ophthalmology2014-07-0422 citations

Pegaptanib sodium for macular edema secondary to central retinal vein occlusion.

2009-04-0152 citations